Current
Neuro-Oncology


Volume 19 Number 5
31 May 2017


Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 5, 31 May






Bosnyák E, Michelhaugh SK, Klinger NV, Kamson DO, Barger GR, Mittal S, Juhász C.
Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.
Clin Nucl Med. 2017 May;42(5):341-347
. doi: 10.1097/RLU.0000000000001577. PMID: 28195901. Observational study. ˍ




Bhandari M, Gandhi AK, Devnani B, Kumar P, Sharma DN, Julka PK.
Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.
J Clin Diagn Res. 2017 May 1, 2017;11(5):XC04-XC08
. doi: 10.7860/JCDR/2017/27611.9945. PMID: 28658891. Interventional study. ˍ




Menon SG, Raju VNJ, Bhandary SV, Addoor KR.
Recurrent Optic Nerve Pilocytic Astrocytoma: A Rare Case.
J Clin Diagn Res. 2017 May 1, 2017;11(5):ND03-ND04
. doi: 10.7860/JCDR/2017/26991.9824. PMID: 28658822. Case report. ˍ




Gittleman H, Kromer C, Ostrom QT, Blanda R, Russell J, Kruchko C, Barnholtz-Sloan JS.
Is mortality due to primary malignant brain and other central nervous system tumors decreasing?
J Neurooncol. 2017 May 3, 2017;133(2):265-275
. doi: 10.1007/s11060-017-2449-1. PMID: 28470430. Observational study. ˍ




Gollapalli K, Ghantasala S, Kumar S, Srivastava R, Rapole S, Moiyadi A, Epari S, Srivastava S.
Subventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlation.
Sci Rep. 2017 May 3, 2017;7(1):1449
. doi: 10.1038/s41598-017-01202-8. PMID: 28469129. Laboratory investigation. ˍ




Kakkar N, Kaur J, Singh GK, Singh P, Siraj F, Gupta A.
Gliosarcoma in Young Adults: A Rare Variant of Glioblastoma.
World J Oncol. 2017 May 4, 2017;8(2):53-57. doi: 10.14740/wjon998w. PMID: 29147435. Case report. ˍ




Jakola AS, Skjulsvik AJ, Myrmel KS, Sjåvik K, Unsgård G, Torp SH, Aaberg K, Berg T, Dai HY, Johnsen K, Kloster R, Solheim O.
Surgical resection versus watchful waiting in low-grade gliomas.
Ann Oncol. 2017 May 5, 2017;28(8):1942-1948
. doi: 10.1093/annonc/mdx230. PMID: 28475680. Observational study. ˍ




Li Q, Guo J, Wang W, Wang D.
Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.
Oncol Lett. 2017 May 5, 2017;14(1):229-233
. doi: 10.3892/ol.2017.6123. PMID: 28693158. Observational study. ˍ




Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS.
Global Incidence of Malignant Brain and Other Central Nervous System Tumors by Histology, 2003-2007.
Neuro Oncol. 2017 May 6, 2017;19(11):1553-1564
. doi: 10.1093/neuonc/nox091. PMID: 28482030. Observational study. ˍ




Huang PI, Lin SC, Lee YY, Ho DM, Guo WY, Chang KP, Chang FC, Liang ML, Chen HH, Liu YM, Yen SH, Wong TT, Chen YW.
Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.
Childs Nerv Syst. 2017 May 9, 2017;33(8):1285-1294
. doi: 10.1007/s00381-017-3435-9. PMID: 28488086. Observational study. ˍ




Algahtani H, Shirah B, Abdullah A, Bazaid A.
Teratoma of the nervous system: A case series.
Neurocirugia (Astur). 2017 May 10, 2018;29(3):143-149
. doi: 10.1016/j.neucir.2017.03.004. PMID: 28501423. Case report. ˍ




Alattar AA, Brandel MG, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen CC.
Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
J Neurosurg. 2017 May 12, 2018;128(4):1076-1083
. doi: 10.3171/2016.11.JNS161974. PMID: 28498059. Observational study. ˍ




Arrillaga-Romany I, Chi AS, Allen JE, Oster W, Wen PY, Batchelor TT.
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma.
Oncotarget. 2017 May 12, 2017;8(45):79298-79304
. doi: 10.18632/oncotarget.17837. PMID: 29108308. Interventional study. ˍ




Bielecka-Wajdman AM, Lesiak M, Ludyga T, Sieroń A, Obuchowicz E.
Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Cancer Chemother Pharmacol. 2017 May 12, 2017;79(6):1249-1256
. doi: 10.1007/s00280-017-3329-2. PMID: 28500556. Laboratory investigation. ˍ




Darmon I, Morisse MC, Coutte A, Blonski M, Rhun EL, Taillandier L, Roufai DB, Desenclos C, Trudel S, Faivre JC, Blanchard N, Chauffert B, Boone M.
Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment.
J Cancer. 2017 May 12, 2017;8(8):1417-1424
. doi: 10.7150/jca.18339. PMID: 28638456. Observational study. ˍ




Yu J, Shi W, Li H.
Factors affecting the prognosis of children with medulloblastoma: A single institution retrospective analysis of 40 cases.
Transl Neurosci Clin. 2017 May 12, 2017;3(1):16-27. doi: 10.6061/clinics/2017(12)12. PMID: 29319727. Observational study. ˍ




Jang SH, Seo JP.
Perilesional Reorganization in a Patient With Brain Tumor.
Am J Phys Med Rehabil. 2017 May 18,
2018;97(4):e31-e32. doi: 10.1097/PHM.0000000000000764. PMID: 2852062. Case report. ˍ




Juhnke BO, Mynarek M, Rutkowski S.
Refining medulloblastoma subgroups.
Lancet Oncol. 2017 May 22, 2017;18(7):847-848
. doi: 10.1016/S1470-2045(17)30332-7. PMID: 28545822. Comment. ˍ
Refers to: Schwalbe EC, et al., Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Lancet Oncol. 2017 May 22, 2017;18(7):958-971
. doi: 10.1016/S1470-2045(17)30243-7. PMID: 28545823.Observational study. ˍ




McDonald JT, Gao X, Steber C, Lee Breed J, Pollock C, Ma L, Hlatky L.
Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation.
PLoS One. 2017 May 22, 2017;12(5):e0178155
. doi: 10.1371/journal.pone.0178155. PMID: 28542439. Laboratory investigation. ˍ




Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, Rafiee G, Hill RM, Iliasova A, Stone T, Pizer B, Michalski A, Joshi A, Wharton SB, Jacques TS, Bailey S, Williamson D, Clifford SC.
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Lancet Oncol. 2017 May 22, 2017;18(7):958-971. doi: 10.1016/S1470-2045(17)30243-7. PMID: 28545823.Observational study. ˍ




Prabhu A, Kesarwani P, Kant S, Graham SF, Chinnaiyan P.
Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
Neuro Oncol. 2017 May 25, 2017;19(12):1599-1606
. doi: 10.1093/neuonc/nox100. PMID: 28541485. Laboratory investigation. ˍ




Wenger KJ, Wagner M, You SJ, Franz K, Harter PN, Burger MC, Voss M, Ronellenfitsch MW, Fokas E, Steinbach JP, Bähr O.
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
Oncol Lett. 2017 May 25, 2017;14(1):1141-1146
. doi: 10.3892/ol.2017.6251. PMID: 28693286. Observational study. ˍ



*

Peng P, Wei W, Long C, Li J.
Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling.
Biochem Biophys Res Commun. 2017 May 26, 2017;489(3):293-298
. doi: 10.1016/j.bbrc.2017.05.147. PMID: 28554840. Laboratory investigation. ˍ




Soheila RD, Alessandro R, Hambra DV, Danilo P, Sabino L, Paola P, Benedetta C, Tempesta D, Coletti G, Cipolloni G, Grazia CM, Renato G.
Stemness Markers Detection In The Periphery Of Glioblastomas And Glioblastoma Ability To Generate Glioma Stem Cells: Clinical Correlations.
World Neurosurg. 2017 May 27, 2017;105:895-905
. doi: 10.1016/j.wneu.2017.05.099. PMID: 28559081. Laboratory investigation. ˍ




Zacharia BE, DiStefano N, Mader MM, Chohan MO, Ogilvie S, Brennan C, Gutin P, Tabar V.
Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
J Neurooncol. 2017 May 27, 2017;134(2):245-251
. doi: 10.1007/s11060-017-2512-y. PMID: 28551847. Observational study. ˍ




Veldhuijzen van Zanten SEM, Lane A, Heymans MW, Baugh J, Chaney B, Hoffman LM, Doughman R, Jansen MHA, Sanchez E, Vandertop WP, Kaspers GJL, van Vuurden DG, Fouladi M, Jones BV, Leach J.
External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
J Neurooncol. 2017 May 30, 2017;134(1):231-240
. doi: 10.1007/s11060-017-2514-9. PMID: 28560664. Observational study. ˍ



*

Villanueva-Meyer JE, Han SJ, Cha S, Butowski NA.
Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.
J Neurooncol. 2017 May 31, 2017;134(1):213-219
. doi: 10.1007/s11060-017-2511-z. PMID: 28567589. Observational study. ˍ